In support of this, we have also observed increased BALF levels of the siderophore lipocalin-2 in smokers and participants with COPD, when compared to control subjects in the SPIROMICS cohort (data not shown). This evidence concerns the gene LCN2 and chronic obstructive pulmonary disease.